Although in several tumor entities, SFRP1 expression or methylation was proposed as a prognostic biomarker (Davaadorj et al. 2016; Zheng et al. 2015; Atschekzei et al. 2012), this was not the case for our cohort of pediatric liver cancers. The gene discussed is SFRP1; the disease is neoplasm.